GRN1005 for Brain Metastases From Breast or Lung Cancer

NCT01679743 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Breast Cancer
Lung Neoplasms
Breast Neoplasms
Lung Cancer

Interventions

DRUG: Trastuzumab
DRUG: GRN 1005

Sponsor

National Cancer Institute (NCI)